Related Experiment Video
Updated: Jun 20, 2026

08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Fungal echinocandin resistance
Louise A Walker1, Neil A R Gow, Carol A Munro
1School of Medical Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
Fungal Genetics and Biology : FG & B
|September 23, 2009
Summary
Echinocandins fight fungal infections by inhibiting beta-(1,3)-glucan synthesis. Fungal resistance emerges from mutations in Fks1 or compensatory chitin upregulation, decreasing drug susceptibility.
Area of Science:
- Mycology
- Biochemistry
- Pharmacology
Background:
- Echinocandins are a novel class of antifungal drugs.
- They inhibit beta-(1,3)-glucan synthesis, a key fungal cell wall component.
- Fungal resistance mechanisms are critical to understand for effective treatment.
Purpose of the Study:
- To investigate mechanisms of fungal resistance to echinocandins.
- To explore both genetic and physiological alterations contributing to resistance.
- To understand how fungi adapt to echinocandin therapy.
Main Methods:
- Analysis of spontaneous mutations in Fks1 hot spot regions.
- Isolation and characterization of echinocandin-resistant fungal strains with unaltered FKS1.
- Investigation of cell wall compensatory mechanisms, including chitin synthesis.
Main Results:
- Spontaneous mutations in Fks1 hot spot regions confer reduced echinocandin sensitivity.
- Fungal strains with wild-type FKS1 also exhibit decreased echinocandin sensitivity.
- Echinocandin treatment can induce compensatory upregulation of chitin synthesis, strengthening the cell wall.
Conclusions:
- Fungal resistance to echinocandins can result from stable genetic mutations or reversible physiological adaptations.
- Understanding these dual resistance mechanisms is crucial for developing strategies against echinocandin-tolerant fungi.
- Compensatory chitin synthesis represents a significant physiological resistance pathway.
Related Concept Videos
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

